Principles for a fit-for-purpose global health architecture
Biopharmaceutical industry’s considerations on key elements for an effective multilateral Pandemic Prevention, Preparedness, and Response (PPR) instrument.
Key elements of this paper include:
- Inclusive and transparent negotiation process
- Efficiency first: the principle of subsidiarity
- A predictable system with aligned expectations
- Complementarity to existing instruments
- A facilitated, predictable access to pathogens
- Promote more equitable access
- Keep borders open and trade flowing
- Protects IP and leverages private sector efficiencies
Related news and resources
#AlwaysInnovating: Pharmaceutical Industry Facts & Figures
This compendium of facts and figures aims to provide a snapshot of the contribution of the pharmaceutical industry. Pharmaceutical companies are at the forefront of developing medicines and vaccines that change how we fight and prevent disease and help solve today’s biggest health challenges. In addition to their contribution to healthier societies, pharmaceutical companies also...
Read more
Statement on the revision of the Declaration of Helsinki on ethical principles for medical research
On 19 October 2024, the World Medical Association (WMA) General Assembly unanimously voted to adopt a set of revisions to the Declaration of Helsinki on ethical principles for medical research.
Read moreResumed 12th session of the Intergovernmental Negotiating Body (INB 12)
On 2 December 2024 in Geneva, IFPMA delivered a statement at the resumed INB 12.
Read more